Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic dexamethasone versus gentamicin for unilateral Ménière's disease
NL-OMON40458Phase 3Withdrawn
- Sponsor
- Gelre ziekenhuizen
- Start
- Dec 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Meniere Disease comparing Intratympanic dexamethasone with Intratympanic gentamicin (2 arms). Primary endpoints: Risk difference between treatments for vertigo control, Number of vertigo attacks and 1 more. Planned start Dec 2013; status: withdrawn.
02
Drugs
dexamethasonegentamicin
03
Conditions
Meniere Disease
Beyond the preview
Go deeper on NL-OMON40458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40458.